Skip to main content

Recorded Webinar Coming Soon

Cardiogenic Shock Live Webinar Series
From Flight To Fight: The Cardiogenic Shock Spectrum Of Care

Featuring webinars on the following topics with LIVE Q&A:

  • March 23, 2021, 6:00pm Central Time - Optimizing And Transporting Patients With Cardiogenic Shock Presented by: Dr. Jeremiah Hayanga, West Virginia University and Dr. M. Cristy Smith, Sacred Heart Medical Center
  • March 30, 2021, 6:00pm Central Time - Mechanical Interventions For Refractory Cardiogenic Shock Presented by: Dr. Jay Pal, University of Colorado and Dr. Scott Silvestry, Advent Health
  • April 6, 2021, 6:00pm Central Time - Bridging Cardiogenic Shock Patients With ECLS Presented by: Duc Pham, MD, Northwestern University and Dr. J. Eduardo Rame, Jefferson Health
  • April 13, 2021, 6:00pm Central Time - HVAD Post ECMO: Recovery To Discharge
    Presented by: Dr. Jonathan Rich, Northwestern University and Dr. Liviu Klein, University of California

Featured Videos

Selecting the Best MCS Program for You

Originally Broadcast: Thursday, January 28, 2021
5:00pm CST

Featuring:

Leslie Sweet, RN - Moderator
Manager, MCS Publication Planning | Medical Affairs and Medical Sciences
Mechanical Circulatory Support
Medtronic US

Scott Silvestry, MD
Surgical Director, Thoracic Transplant Programs
Transplant Institute
AdventHealth

Virtual HVAD Waveform Bootcamp 2-Part Series

Originally Broadcast February 23 & March 2, 2021

Featuring:

Michele Kassemos - Moderator
Marketing Product Consultant
Mechanical Circulatory Support
Medtronic

Michael S. Kiernan, MD, MS, MBA
Medical Director, Ventricular Assist Device Program
Assistant Professor, Tufts Medical Center

Marwan F. Jumean, MD, FACC, FSCAI
Interventional Heart Failure Cardiologist
Associate Professor, UTHealth

Jennifer Pavone, MS, RN, AGACNP-BC
Director, Transplant Operations
NYU Langone Health

VAD Therapy Trends: Why Meaningful Data Matters

Thursday, December 10, 2020
8:00am CST

Featuring:

Mark Slaughter, MD - Moderator
Professor and Chair, Department of Cardiovascular and Thoracic Surgery Executive Medical Director, Jewish Hospital,
Director Heart Transplant and Mechanical Assist Device, University of Louisville,
Jewish Hospital and St. Mary's Healthcare System

Anson Cheung, MD
Director, Cardiac Transplantation of British Columbia
Clinical Associate Professor of Surgery
University of British Columbia
St. Paul's Hospital

Erika Feller, MD
Associate Professor of Medicine
Medical Director, Mechanical Circulatory Support and Transplant
Director of Cardiology Clinical Research
University of Maryland Medical Center

Prof. Dr. med. Evgenij V. Potapov
Senior Cardiac Surgeon
Head Ventricular Assist Device Team
Department of Cardiothoracic and Vascular Surgery
Deutsches Herzzentrum Berlin

Christopher T. Salerno, MD, FACS, FACC
Surgical Director Heart Transplant and Mechanical Assist Device Program
St. Vincent Heart Center of Indiana
Chief, Cardiothoracic Surgery
Vice Chair Surgery
St Vincent Hospital Indianapolis

Stephan Schueler, MD, PhD, FRCS
Consultant Cardiothoracic and Transplant Surgeon
Freeman Hospital
Newcastle upon Tyne

Discover What’s New: HVAD Webinar Series

Discover KOL perspectives on best practices in VAD therapy. Register today to watch a comprehensive,
5-part webinar series hosted by Medtronic MCS, on

Optimizing Best Practices for LVAD Patient Management
Perspectives of Key Opinion Leaders in Mechanical Circulatory Support

Featuring webinars on the following topics with LIVE Q&A:

  • June 18, 2020, 3:00pm Central Time - HVAD Patient Selection Considerations, presented by Dr. Andrew Sauer, University of Kansas Medical Center
  • June 25, 2020, 3:00pm Central Time - Thoracotomy VAD Implantation, presented by Dr. Jay Pal, University of Colorado
  • July 2, 2020, 3:00pm Central Time - Post-operative Patient Management, presented by Dr. Erika Feller, University of Maryland
  • July 9, 2020, 3:00pm Central Time - HVAD Patient Management, presented by Dr. Jonathan Rich, Northwestern University
  • July 23, 2020, 3:00pm Central Time - Optimizing HVAD Patient Outcomes: The Texas Heart Experience, presented by Dr. Andrew Civitello, Baylor St. Luke's Medical Center / Texas Heart Institute

LVAD Patient Management In An Era Of COVID-19

Friday, May 22, 2020
3:00-4:00pm CDT

Recorded video now available

Featuring:

Liviu Klein, M.D.
Director of MCS and Heart Failure Device Programs
Director of Cardiology Clinical Research
Associate Professor of Cardiology at UCSF
San Francisco, California

Gregory Macaluso, M.D.
Clinical Assistant Professor of Medicine, University of Illinois at Chicago
Fellowship Director, Advanced Heart Failure, University of Illinois at Chicago/Advocate Christ Medical Center
Chicago, Illinois

Erin Davis, B.S.N., R.N.
Cardiothoracic Transplant, MCS and Heart Failure Program Manager
University of Utah
Salt Lake City, Utah

Robert Kowal, M.D. - Moderator
Vice President Medical Affairs and Chief Medical Officer
Medtronic Cardiac Rhythm Heart Failure

Experience from the Front Lines: Managing Heart Failure Programs During the COVID-19 Pandemic

Thursday, April 16, 2020
2:00-3:00pm CDT

Recorded video now available

Featuring:

Claudius Mahr, DO, FACC, FESC
Clinical Professor, Medicine
Medical Director, Mechanical Circulatory Support Program
University of Washington
Seattle, Washington

Prof. Dr. Federico Pappalardo
Intensive Care and Anesthesia Unit
Vita Salute San Raffaele University

Robert Kowal, MD - Moderator
Vice President Medical Affairs and Chief Medical Officer
Medtronic Cardiac Rhythm Heart Failure

Pieter Kappetein, MD - Moderator
Vice President and Chief Medical Officer
Medtronic Structural Heart and Cardiac Surgery

VAD Patient Management During the COVID-19 Pandemic
ICCAC Roundtable to Connect, Inform, Learn and Support Each Other

Sponsored by Medtronic

Friday, March 27, 2020
3:00pm Eastern Time

Recorded video now available

Featuring:

Sarah Schroeder, ACNP-BC, MSN, RN
Mechanical Circulatory Support (MCS) Nurse Practitioner and Program Coordinator
Bryan Heart
Lincoln, Nebraska

Lori Anderson, MS, RN, CHFN
Nurse Manager, MCS Program
Advanced Organ Disease and Transplantation Institute
Tampa General Hospital
Tampa, FL

Krista Marz, BSN, CCRN
VAD Coordinator
Ochsner Foundation
New Orleans, Louisiana

Susan Wright, MS, RN - MODERATOR
Principal, Training/Education Specialist
Medtronic, Inc.

Tips & Tricks

Brief Statement HeartWare™ HVAD™ System
Indications For Use:The HeartWare™ HVAD™ System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a Bridge to Cardiac Transplantation (BTT), myocardial recovery, or as Destination Therapy (DT) in patients for whom subsequent transplantation is not planned.
Contraindications: The HeartWare System is contraindicated in patients who cannot tolerate anticoagulation therapy. Warnings/Precautions: Proper usage and maintenance of the HVAD™ System is critical for the functioning of the device. Serious and life-threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD™ Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia, and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta — use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post-CPR.
Potential Complications: Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and devicerelated thromboembolic events, bleeding, right ventricular failure, infection, hemolysis, and sepsis. Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events prior to using this device.
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

Indications, Safety and Warnings
Outside US Statement: HeartWare™ HVAD™ System
Indications for Use
The HVAD™ System is intended for use in patients at risk of death from refractory end-stage heart failure. The HVAD™ System is designed for in-hospital and out-of-hospital settings, including transportation via fixed wing aircraft or helicopter.
Contraindications
The HVAD™ System is contraindicated:

  • In patients with a body surface area (BSA) less than 1.2m2
  • In patients who cannot tolerate anticoagulation therapy
  • During pregnancy

Warnings/Precautions
Proper usage and maintenance of the HVAD™ System is critical for the functioning of the device. Serious and life threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD™ Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta -use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post CPR. Potential Complications Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and device-related thromboembolic events, bleeding, right ventricular failure, infection, hemolysis and sepsis. Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions and potential adverse events prior to using this device.